Literature DB >> 860894

A comparison study of amitriptyline and nortriptyline with plasma levels.

V E Ziegler, P J Clayton, J T Biggs.   

Abstract

Forty-one depressed outpatients were treated for six weeks after random assignment to amitriptyline hydrochloride (N = 22) or nortriptyline hydrochloride (N = 19). On a mean daily dose of 119 mg, amitriptyline-treated patients had a mean tricyclic level (amitriptyline plus nortriptyline) of 120 ng/ml. Nortriptyline-treated patients on a mean dose of 117 mg/day had a mean nortriptyline level of 141 ng/ml. The two drugs were equally effective in the treatment of depression. The correlation between the Hamilton Score and the mean tricyclic level was negative in the amitriptyline-treated patients (r = -0.54, P less than .025) and positive in the nortriptyline-treated patients (r = -0.49, P less than .05). Patients treated with amitriptyline or nortriptyline with plasma levels within the therapeutic range, defined in other laboratories, had a better response, as measured by the Hamilton Score (P less than .001), Zung Score (P less than .01), and percent recovered (P less than .001), than those above or below the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 860894     DOI: 10.1001/archpsyc.1977.01770170117012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  24 in total

1.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.

Authors:  G L Corona; M L Cucchi; P Frattini; G Santagostino; S Schinelli; F Zerbi; F Savoldi
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Amitriptyline plasma concentrations and clinical response.

Authors:  S A Montgomery; R McAuley; S J Rani; D R Montgomery; R Braithwaite; S Dawling
Journal:  Br Med J       Date:  1979-06-23

Review 4.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

5.  Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.

Authors:  M L Rao
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Tricyclic plasma levels in depressed outpatients treated with amitriptyline.

Authors:  K Rickels; C Weise; G Case; H Hucker
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.

Authors:  P Bech; P Allerup; N Reisby; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens.

Authors:  S Montgomery; R McAuley; D B Montgomery
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

9.  The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.

Authors:  J E Burch
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.

Authors:  G M Simpson; E H Pi; E Abdelmalek; J L Boyd; R S Carroll; T B Cooper; A Miller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.